| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/16/2008 | CN100361973C Benzyloxy-substituted tryptophan derivative, its analogs, production and use thereof |
| 01/16/2008 | CN100361970C Nover diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use |
| 01/16/2008 | CN100361947C Bromophenol compound and its prepn and application |
| 01/16/2008 | CN100361674C Chinese medicine extract with function of reducing blood-sugar and preparing method |
| 01/16/2008 | CN100361666C Kudzu vine capsule for regulating blood pressure and blood fat, its preparation process |
| 01/16/2008 | CN100361665C Compositions and methods for treatment of mitochondrial diseases |
| 01/16/2008 | CN100361659C Composite vitamin B powdery injection for venous infusion and preparation thereof |
| 01/16/2008 | CN100361654C Body-building weight-reducing capsule and its preparation process |
| 01/16/2008 | CN100361604C Pumpkin juice for diabetes patients |
| 01/15/2008 | US7319109 4-(Substituted phenoxy or anilino)-3-phenyl- or phenylalkylisoxazoles: 3-{[(4-{[3-(2,6-Dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy}-2-methylphenyl)-(methyl)amino]methyl}benzoic acid; cardiovascular disease, cholestatic liver disease, organ fibrosis, triglycerides, increasing high density lipoprotein |
| 01/15/2008 | US7319107 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7319100 1-(1H-Pyrazin-2-on-3-yl)tetrahydroquinolines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); treating anxiety and depression |
| 01/15/2008 | US7319097 Treatment of type II diabetes with benzenesulfonamide substituted with an N-heterocycle: N-[2-amino-5-(1,4-diazepan-1-yl)phenyl]benzenesulfonamide, N-[4-amino-5-(piperazinyl)phenyl]benzenesulfonamide, 3-amino-4-(5-methyl-2,5-diaza-bicyclo[2.2.1]hept-2-yl)-N-phenyl-benzenesulfonamide hydrochloride |
| 01/15/2008 | US7319093 Antidiabetic 2-substituted-5′-O-(1-Boranotriphosphate) adenosine derivatives |
| 01/15/2008 | CA2419934C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/15/2008 | CA2290331C Phytosterol and/or phytostanol derivatives |
| 01/15/2008 | CA2253130C A medicament for treating obesity and improving lipid metabolism |
| 01/15/2008 | CA2210684C Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 01/10/2008 | WO2008006044A2 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/10/2008 | WO2008006043A2 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents |
| 01/10/2008 | WO2008005964A2 Phosphonate and phosphinate compounds as glucokinase activators |
| 01/10/2008 | WO2008005910A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 01/10/2008 | WO2008005576A1 Modulators of metabolism and the treatment of disorders related thereto |
| 01/10/2008 | WO2008004598A1 Erythropoietin-producing organoid precursor, method of constructing the same and method of treating erythropoietin-related disease |
| 01/10/2008 | WO2008004341A1 α-SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES |
| 01/10/2008 | WO2008003753A1 Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity |
| 01/10/2008 | WO2008003611A1 Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-hsd 1) |
| 01/10/2008 | WO2008003484A2 Agent containing chrysin and cholic acid for reducing weight, accelerating lipid catabolism, and/or restricting calories |
| 01/10/2008 | WO2008003226A1 Caulis allii fistulosum extract and the use in modulating blood-lipids and lowering cholesterols thereof |
| 01/10/2008 | WO2007137107A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/10/2008 | WO2007122382A3 Lycopene for the treatment of metabolic dysfunction |
| 01/10/2008 | WO2007093853A3 Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols |
| 01/10/2008 | US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid; |
| 01/10/2008 | US20080009533 Glycine, N-[[3-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methoxy]phenyl]methyl]-N-(methoxycarbonyl)-, used for treating atherosclerosis, dyslipidemia, diabetes, non-insulin dependent diabetes, hyperglycemia, hyperinsulinemia and obesity |
| 01/10/2008 | US20080009531 5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes |
| 01/10/2008 | US20080009530 Therapeutic Agent for Diabetes |
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009524 Such as 5'-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-2'-methyl-N-(methylsulfonyl)biphenyl-3-carboxamide; cystic fibrosis transmembrane conductance regulator disorders |
| 01/10/2008 | US20080009522 Biphenylcarboxamides useful as lipid lowering agents |
| 01/10/2008 | US20080009521 Aryl Piperidine Amides |
| 01/10/2008 | US20080009513 Therapeutic agents |
| 01/10/2008 | US20080009512 Tetrahydroquinolones and Aza-Analogues Thereof for Use as Dpp-IV Inhibitors in the Treatment of Diabetes |
| 01/10/2008 | US20080009510 Fused Aminopiperidine as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/10/2008 | US20080009503 Method of treating diabetes |
| 01/10/2008 | US20080009480 CYCLOPENTA[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES |
| 01/10/2008 | US20080009478 Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases |
| 01/10/2008 | US20080009477 Arylalkyl Ureas As Cb1 Antagonists |
| 01/10/2008 | US20080009465 Novel glucokinase activators and methods of using same |
| 01/10/2008 | US20080009457 Reaction of Rna and cochleate |
| 01/10/2008 | US20080009440 Soothing Agent and Food for Treating Fatigue |
| 01/10/2008 | US20080009433 Use of glp-1 or analogs in treatment of myocardial infarction |
| 01/10/2008 | US20080009025 Protein kinase regulation |
| 01/10/2008 | US20080008770 contains calcium; dietetics |
| 01/10/2008 | US20080008754 Pharmaceutical Compositions Comprising (+)-(2S,3S)-2-(3-Chlorophenyl)-3,5,5-Trimethyl-2-Morpholinol |
| 01/10/2008 | US20080008695 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof |
| 01/10/2008 | US20080008689 Method for Transdifferentiation of Non Pancreatic Stem Cells to the Pancreatic Differentiation Pathway |
| 01/10/2008 | US20080008685 Viral vectors |
| 01/10/2008 | CA2658060A1 Erythropoietin-producing organoid precursor, production method thereof, and method for treating erythropoietin-related disorder |
| 01/10/2008 | CA2658001A1 Novel glucokinase activators and methods of using same |
| 01/10/2008 | CA2656703A1 Agent containing chrysin and cholic acid for reducing weight, accelerating lipid catabolism, and/or restricting calories |
| 01/10/2008 | CA2656623A1 Modulators of metabolism and the treatment of disorders related thereto |
| 01/10/2008 | CA2656520A1 Modulators of metabolism and the treatment of disorders related thereto |
| 01/10/2008 | CA2650433A1 Method of treatment of hereditary hemochromatosis |
| 01/09/2008 | EP1876239A1 Degranulation inhibitor |
| 01/09/2008 | EP1876238A1 Novel polypeptide and use thereof |
| 01/09/2008 | EP1876179A1 Thienopyrimidone compound |
| 01/09/2008 | EP1876167A1 Crystal polymorphism of 4 -{2-ý(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino¨ethoxy}-3-isopropyl-3 ,5 -dimethylbiphenylcarboxylic acid hydrochloride |
| 01/09/2008 | EP1875921A1 Dpp4 inhibitor and pharmaceutical application thereof |
| 01/09/2008 | EP1875920A2 Partially denatured whole soybean extracts and methods of use therefore |
| 01/09/2008 | EP1875908A1 Use of Chrysin |
| 01/09/2008 | EP1875904A1 Methods |
| 01/09/2008 | EP1874813A2 Trimeric peptides for use in treating obesity |
| 01/09/2008 | EP1874787A1 Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors |
| 01/09/2008 | EP1874741A1 Azole derivatives in the form of lipase and phospholipase inhibitors |
| 01/09/2008 | EP1874737A1 Substituted 2-amin0alkylthi0-benzimidaz0les and use thereof for reducing blood sugar levels |
| 01/09/2008 | EP1874736A2 Fused heterocyclic compounds |
| 01/09/2008 | EP1874330A2 Peptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1 |
| 01/09/2008 | EP1874308A1 Roflumilast for the treatment of diabetes mellitus |
| 01/09/2008 | EP1874306A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 01/09/2008 | EP1874304A2 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 01/09/2008 | EP1874301A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 01/09/2008 | EP1874285A2 Complementary compositions to reduce blood glucose levels and treat diabetes |
| 01/09/2008 | EP1874140A1 Peptides having a health benefit and compositions comprising them |
| 01/09/2008 | EP1711473B1 Substituted n-cyclohexylimidazolinones having an mch-modulatory effect |
| 01/09/2008 | EP1561468B1 Pharmaceutical antidiabetic composition |
| 01/09/2008 | EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels |
| 01/09/2008 | EP1399531B1 Methods and formulations for enhancing the dissolution of a solid material in liquid |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | EP1377183B1 Cactaceae-based formulation having the property of fixing fats, and method for obtaining same |
| 01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/09/2008 | EP1044009B1 Methods and compositions employing red rice fermentation products |
| 01/09/2008 | CN101103035A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 01/09/2008 | CN101103032A 双环吡咯衍生物 Bicyclopyrrole derivatives |
| 01/09/2008 | CN101103015A 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver X receptor modulators |
| 01/09/2008 | CN101103013A 1-thio-D-glucitol derivatives |
| 01/09/2008 | CN101102817A Satiety emulsions and food compositions |
| 01/09/2008 | CN101102768A Method and composition for the treatment of hyperlipidemia |
| 01/09/2008 | CN101100472A 4-amino-5,6-substituted thiopheno [2,3-D] pyrimidines compound and its uses |